
The new site will expand research capabilities across immunology, neuroscience and oncology

The use of Rinvoq in non-segmental vitiligo is under regulatory review by the US FDA

Rinvoq is the first and only systemic medication approved in the EU for NSV

Globally, an estimated 64 million people have psoriasis, with about 80-90% of those having plaque psoriasis

The acquisition includes clinical-stage candidates for atopic dermatitis and asthma

Spanning four dimensions of skin health, the framework introduces 15 terms and definitions

There are more than three million people affected by IBD globally, with a need to improve current treatments

The new programme addresses the urgent unmet medical need for new therapies to tackle antibiotic-resistant infections

The pharma company has also pledged a $100bn investment in US infrastructure over the next decade

The drug is the first IL-23 inhibitor approved for children from the age of six

Follicular lymphoma affects around 15,000 people in the US every year

Around 700,000 people in the US are living with some form of the autoimmune disease